Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012 KJ Looker, AS Magaret, KME Turner, P Vickerman, SL Gottlieb, ... PloS one 10 (1), e114989, 2015 | 1144 | 2015 |
Herpes simplex virus: global infection prevalence and incidence estimates, 2016 C James, M Harfouche, NJ Welton, KME Turner, LJ Abu-Raddad, ... Bulletin of the World Health Organization 98 (5), 315, 2020 | 545 | 2020 |
The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence KME Turner, S Hutchinson, P Vickerman, V Hope, N Craine, N Palmateer, ... Addiction 106 (11), 1978-1988, 2011 | 415 | 2011 |
Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis KJ Looker, JAR Elmes, SL Gottlieb, JT Schiffer, P Vickerman, KME Turner, ... The Lancet infectious diseases 17 (12), 1303-1316, 2017 | 282 | 2017 |
The re-emergence of syphilis in the United Kingdom: the new epidemic phases I Simms, KA Fenton, M Ashton, KME Turner, EE Crawley-Boevey, ... Sexually transmitted diseases 32 (4), 220-226, 2005 | 272 | 2005 |
Impact of opioid substitution therapy on antiretroviral therapy outcomes: a systematic review and meta-analysis AJ Low, G Mburu, NJ Welton, MT May, CF Davies, C French, KM Turner, ... Clinical Infectious Diseases 63 (8), 1094-1104, 2016 | 245 | 2016 |
First estimates of the global and regional incidence of neonatal herpes infection KJ Looker, AS Magaret, MT May, KME Turner, P Vickerman, LM Newman, ... The Lancet Global Health 5 (3), e300-e309, 2017 | 237 | 2017 |
Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings P Vickerman, N Martin, K Turner, M Hickman Addiction 107 (11), 1984-1995, 2012 | 192 | 2012 |
Advances in human palaeopathology R Pinhasi, S Mays John Wiley & Sons, 2008 | 191 | 2008 |
Risk of Pelvic Inflammatory Disease Following Chlamydia trachomatis Infection: Analysis of Prospective Studies With a Multistate Model MJ Price, AE Ades, D De Angelis, NJ Welton, J Macleod, K Soldan, ... American journal of epidemiology 178 (3), 484-492, 2013 | 187 | 2013 |
The natural history of Chlamydia trachomatis infection in women: a multi-parameter evidence synthesis. MJ Price, AE Ades, K Soldan, NJ Welton, J Macleod, I Simms, ... Health technology assessment (Winchester, England) 20 (22), 1-250, 2016 | 175 | 2016 |
Assessing the reliability of eBURST using simulated populations with known ancestry KME Turner, WP Hanage, C Fraser, TR Connor, BG Spratt BMC microbiology 7, 1-14, 2007 | 167 | 2007 |
Risk of reproductive complications following chlamydia testing: a population-based retrospective cohort study in Denmark B Davies, KME Turner, M Frølund, H Ward, MT May, S Rasmussen, ... The Lancet Infectious Diseases 16 (9), 1057-1064, 2016 | 161 | 2016 |
The secret life of the multilocus sequence type KME Turner, EJ Feil International journal of antimicrobial agents 29 (2), 129-135, 2007 | 157 | 2007 |
Effectiveness and cost-effectiveness of traditional and new partner notification technologies for curable sexually transmitted infections: observational study, systematic … CL Althaus, KME Turner, CH Mercer, P Auguste, TE Roberts, G Bell, ... Health technology assessment (Winchester, England) 18 (2), 1-viii, 2014 | 130 | 2014 |
Global and regional estimates of the contribution of herpes simplex virus type 2 infection to HIV incidence: a population attributable fraction analysis using published … KJ Looker, NJ Welton, KM Sabin, S Dalal, P Vickerman, KME Turner, ... The Lancet Infectious Diseases 20 (2), 240-249, 2020 | 127 | 2020 |
The cost effectiveness of opportunistic chlamydia screening in England EJ Adams, KME Turner, WJ Edmunds Sexually transmitted infections 83 (4), 267-275, 2007 | 118 | 2007 |
Modelling the effectiveness of chlamydia screening in England KME Turner, EJ Adams, DS LaMontagne, L Emmett, K Baster, ... Sexually transmitted infections 82 (6), 496-502, 2006 | 108 | 2006 |
Modelling bacterial speciation WP Hanage, BG Spratt, KME Turner, C Fraser Philosophical Transactions of the Royal Society B: Biological Sciences 361 …, 2006 | 108 | 2006 |
Developing a realistic sexual network model of chlamydia transmission in Britain KME Turner, EJ Adams, N Gay, AC Ghani, C Mercer, WJ Edmunds Theoretical biology and medical modelling 3, 1-11, 2006 | 99 | 2006 |